eli lilly weight loss drug retatrutide π₯ Lillyβs next generation weight-loss drug, Retatrutide, could hit the shelves soon. Though the treatment has yet to attain FDA approval, demand is already so heavy that consumers are going to the Eli Lilly's experimental obesity drug
Description
These mechanisms are consistent with those previously identified across several of the 60 complex chronic diseases studied by PrecisionLife, including pathways linked to addiction and neuroplasticity
Route, form, and dosage: Mounjaro comes in a self-injectable pen that you inject under the skin once a week

Specifically, you have to have a BMI of 30 or higher to qualify or have a BMI of 27-30 with at least one comorbid condition like diabetes or hypertension

[DOI] [PubMed] [Google Scholar] 32.Baggio L, Adatia F, Bock T, Brubaker PL, Drucker DJ
doi: Walker E, Lo K, Tham S, et al
